PCIA
FLGT icon

Prime Capital Investment Advisors’s Fulgent Genetics FLGT Stock Holding History

Prime Capital Investment Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,185
Closed -$268K – 1075
2025
Q4 		$268K Hold
10,185
– – ﹤0.01% 866
2025
Q3 		$230K Sell
10,185
-7
-0.1% -$144 ﹤0.01% 898
2025
Q2 		$203K Sell
10,192
-95
-0.9% -$1.85K ﹤0.01% 897
2025
Q1 		$174K Buy
10,287
+67
+0.7% +$1.14K ﹤0.01% 986
2024
Q4 		$189K Sell
10,220
-19
-0.2% -$371 ﹤0.01% 867
2024
Q3 		$222K Sell
10,239
-120
-1% -$2.68K ﹤0.01% 830
2024
Q2 		$203K Sell
10,359
-84
-0.8% -$1.75K ﹤0.01% 852
2024
Q1 		$227K Sell
10,443
-184
-2% -$4.57K ﹤0.01% 883
2023
Q4 		$307K Sell
10,627
-5,005
-32% -$134K ﹤0.01% 730
2023
Q3 		$418K Buy
15,632
+18
+0.1% +$614 0.01% 501
2023
Q2 		$578K Buy
+15,614
New +$544K 0.01% 445
2021
Q2 		– Sell
-533
Closed -$51K – 433
2021
Q1 		$51K Buy
533
+112
+27% +$11.6K ﹤0.01% 332
2020
Q4 		$22K Buy
+421
New +$17.6K ﹤0.01% 375

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Prime Capital Investment Advisors's FLGT Position: Q1 2026 in Review

Prime Capital Investment Advisors sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 10,185 shares — an estimated $268K sold.

Prime Capital Investment Advisors first reported a position in FLGT in Q4 2020 and held it in 13 quarters. The position peaked at $578K in Q2 2023. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Prime Capital Investment Advisors reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 10,185 Fulgent Genetics shares in Q1 2026, an estimated $268K.
  • Prime Capital Investment Advisors first reported a position in Fulgent Genetics in Q4 2020 and held it in 13 quarters.
  • Prime Capital Investment Advisors's Fulgent Genetics position peaked at $578K in Q2 2023.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.